GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precigen Inc (NAS:PGEN) » Definitions » Cyclically Adjusted PB Ratio

Precigen (Precigen) Cyclically Adjusted PB Ratio : 0.42 (As of May. 15, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Precigen Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Precigen's current share price is $1.37. Precigen's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $3.28. Precigen's Cyclically Adjusted PB Ratio for today is 0.42.

The historical rank and industry rank for Precigen's Cyclically Adjusted PB Ratio or its related term are showing as below:

PGEN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.3   Med: 0.4   Max: 0.65
Current: 0.41

During the past years, Precigen's highest Cyclically Adjusted PB Ratio was 0.65. The lowest was 0.30. And the median was 0.40.

PGEN's Cyclically Adjusted PB Ratio is ranked better than
77.92% of 643 companies
in the Biotechnology industry
Industry Median: 1.78 vs PGEN: 0.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Precigen's adjusted book value per share data for the three months ended in Dec. 2023 was $0.476. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.28 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Precigen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Precigen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precigen Cyclically Adjusted PB Ratio Chart

Precigen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.49 0.41

Precigen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.34 0.33 0.42 0.41

Competitive Comparison of Precigen's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Precigen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precigen's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Precigen's Cyclically Adjusted PB Ratio falls into.



Precigen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Precigen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.37/3.28
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precigen's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Precigen's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.476/129.4194*129.4194
=0.476

Current CPI (Dec. 2023) = 129.4194.

Precigen Quarterly Data

Book Value per Share CPI Adj_Book
201403 4.210 99.695 5.465
201406 3.770 100.560 4.852
201409 3.565 100.428 4.594
201412 3.826 99.070 4.998
201503 5.904 99.621 7.670
201506 4.327 100.684 5.562
201509 6.173 100.392 7.958
201512 5.950 99.792 7.716
201603 5.658 100.470 7.288
201606 5.236 101.688 6.664
201609 5.070 101.861 6.442
201612 4.720 101.863 5.997
201703 4.421 102.862 5.562
201706 4.575 103.349 5.729
201709 4.424 104.136 5.498
201712 4.371 104.011 5.439
201803 4.280 105.290 5.261
201806 4.248 106.317 5.171
201809 3.933 106.507 4.779
201812 2.268 105.998 2.769
201903 1.949 107.251 2.352
201906 1.724 108.070 2.065
201909 1.406 108.329 1.680
201912 0.439 108.420 0.524
202003 0.511 108.902 0.607
202006 0.288 108.767 0.343
202009 0.328 109.815 0.387
202012 0.358 109.897 0.422
202103 0.847 111.754 0.981
202106 0.771 114.631 0.870
202109 0.635 115.734 0.710
202112 0.519 117.630 0.571
202203 0.356 121.301 0.380
202206 0.267 125.017 0.276
202209 0.685 125.227 0.708
202212 0.607 125.222 0.627
202303 0.721 127.348 0.733
202306 0.651 128.729 0.654
202309 0.576 129.860 0.574
202312 0.476 129.419 0.476

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precigen  (NAS:PGEN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Precigen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Precigen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precigen (Precigen) Business Description

Industry
Traded in Other Exchanges
Address
20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Executives
Jeffrey B Kindler director 35 E. 62ND ST, NEW YORK NY 10065
Randal J Kirk director, 10 percent owner, officer: Chief Executive Officer 1881 GROVE AVENUE, RADFORD VA 24141
Dean J Mitchell director C/O BRISTOL MYERS SQUIBB CO, 345 PARK AVE, NEW YORK NY 10164
Helen Sabzevari director, officer: President and CEO 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Rutul R Shah officer: Chief Operating Officer C/O PRECIGEN, INC., 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Harry Jr. Thomasian officer: Chief Financial Officer C/O PRECIGEN, INC., 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876
Jeffrey Thomas Perez officer: SVP, IP Affairs 20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Donald P. Lehr officer: Chief Legal Officer 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Fred Hassan director C/O CARET GROUP,, 1100 HOLLAND DR., BOCA RATON FL 33487
Steven Frank director 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Vinita D Gupta director 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Robert B Shapiro director 155 WEST BURTON PLACE, #2, CHICAGO IL 60610
Cesar L Alvarez director C/O PEDIATRIX MEDICAL GROUP, LEGAL DEPT 1301- CONCORD TERRACE, SUNRISE FL 33323
James S Turley director 9 MUIRFIELD LANE, SAINT LOUIS MO 63141
Ares Trading S.a. 10 percent owner ZONE INDUSTRIELLE DE L'OURIETTAZ, AUBONNE V8 1170